ASH Clinical News July 2017 V2 - Page 37

The AmericAn SocieTy of hemATology preSenTS: ACUTE MYELOID LEUKEMIA MATTERS: Multidisciplinary Approach To Testing and Diagnosis, Evaluation of Risk, and Personalized Treatment Selection Are you recognizing and diagnosing Aml promptly? Are you confident with disease classification and risk stratification for your patients with Aml? earn 5.5 cme credits/cne contact hours at a complimentary summit friday, July 28, 2017 minneApoliS, mn friday, october 20, 2017 durhAm, nc friday, october 27, 2017 philAdelphiA, pA 8:00 Am –2:30 pm national marrow donor program © / Be The match © 500 n 5th Street 8:00 Am –2:30 pm The Washington duke inn & golf club 3001 cameron Boulevard 8:00 Am –2:30 pm chemical heritage foundation 315 chestnut Street Who should attend? hematologists • medical oncologists • pathologists • hematopathologists • medical laboratory Scientists pathologists’ Assistants • physician Assistants • hematology and oncology nurse practitioners • clinical nurses register today! or call 866-856-1998 STeering commiTTee The goal of the summits is to improve the diagnosis and treatment of Acute Myeloid Leukemia patients. Participants will actively engage in multidisciplinary, interactive small-group activities, including: • A case-based tumor board • Diagnosing AML Jessica K. Altman, md (chair) heidi Klepin, md Northwestern University Feinberg School of Medicine Wake Forest Baptist Health Annemarie Block, phd, fAcmg Stanford University Medical Center Roswell Park Cancer Institute • Treatment decision-making linda J. Burns, md • MRD/CR1 and the role of transplants National Marrow Donor Program/ Be The Match • Relapsed refractory disease Funded by an independent educational grant from Celgene Corporation. Bruno c. medeiros, md martin Tallman, md Memorial Sloan Kettering Cancer Center robert paul hasserjian, md Kathleen Wiley, rn, mSn, AocnS Harvard Medical School Oncology Nursing Society crediT deSignATion STATemenTS: For Physicians: The American Society of Hematology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASH designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For Nurses: The Oncology Nursing Society is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850. This activity is awarded 5.5 contact hours of continuing nursing education for RNs. Hosted in partnership by